Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07185399 · ClinicalTrials.gov registry record · Phase 4

Systems Biological Analysis of Immune Responses to RSV Vaccine

A Phase 4 study of Respiratory Syncytial Virus (RSV), sponsored by Emory University.

Active
Registry status
Phase 4
Development phase
14
Enrollment target
1
Study location

NCT07185399 is a Phase 4 study of Respiratory Syncytial Virus (RSV) that is active but no longer recruiting, run by Emory University. The registered enrollment target is 14 participants, below the 6,755-participant average among 11 other Respiratory Syncytial Virus (RSV) trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07185399, a Phase 4 study of Respiratory Syncytial Virus (RSV), is active but no longer recruiting, sponsored by Emory University.

ACTIVE NOT RECRUITING
Registry status
Phase 4
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to characterize the immune response to the FDA-approved mRNA-based RSV vaccine in adults ≥60 years of age, using a systems biology approach. The study aims to generate high-resolution immunologic and systems biology data following vaccination to identify early biomarkers of response and gain mechanistic insight into host immunity.

Conditions Studied

Respiratory Syncytial Virus (RSV)

Interventions

  • BIOLOGICAL Moderna RSV vaccine

Study Locations (1)

Georgia

  • The Hope Clinic of the Emory Vaccine Center - Decatur

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2025-10-13
Est. Completion 2026-07
Phase Phase 4

Sponsor

Emory University

1,208 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07185399

The ClinicalTrials.gov registry entry for NCT07185399 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,755-participant average among 11 other Respiratory Syncytial Virus (RSV) trials with a reported enrollment target (100% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Respiratory Syncytial Virus (RSV) appearing as the primary indexed condition, and to 1 intervention - of which Moderna RSV vaccine is the first listed.

NCT07185399 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT07185399 about?

NCT07185399 is a clinical study titled "Systems Biological Analysis of Immune Responses to RSV Vaccine". The purpose of this study is to characterize the immune response to the FDA-approved mRNA-based RSV vaccine in adults ≥60 years of age, using a systems biology approach. The study aims to generate high-resolution immunologic and systems biology data following vaccination to identify early biomarkers...

What is the current status of trial NCT07185399?

This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 14 participants. The study started on 2025-10-13. Estimated completion is 2026-07.

What conditions does trial NCT07185399 study?

This clinical trial studies the following conditions: Respiratory Syncytial Virus (RSV).

What interventions are being tested in trial NCT07185399?

The interventions under investigation include: Moderna RSV vaccine (BIOLOGICAL).

Who is sponsoring clinical trial NCT07185399?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07185399 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Respiratory Syncytial Virus (RSV)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Respiratory Syncytial Virus (RSV)

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.